Hypoglycemic sulfonylureas represent a group of clinically useful anti
diabetic compounds that stimulate insulin secretion from pancreatic be
ta cells. The molecular mechanisms involved are not fully understood b
ut are believed to involve inhibition of potassium channels sensitive
to adenosine triphosphate (K-ATP channels) in the beta cell membrane,
causing membrane depolarization, calcium influx, and activation of the
secretory machinery. In addition to these effects, sulfonylureas also
promoted exocytosis by direct interaction with the secretory machiner
y not involving closure of the plasma membrane K-ATP channels. This ef
fect was dependent on protein kinase C (PKC) and was observed at thera
peutic concentrations of sulfonylureas, which suggests that it contrib
utes to their hypoglycemic action in diabetics.